CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to increase growth hormone (GH) secretion. There are two main forms: CJC-1295 with DAC (Drug Affinity Complex), which has an extended half-life allowing less frequent dosing, and CJC-1295 without DAC (No DAC), which has a shorter half-life and requires more frequent administration.
This article examines CJC-1295 across five domains β macro-level systems, mechanistic pathways, safety considerations, application strategies, and emerging research directions β providing a structured overview for researchers.
Biological Systems Affected
- Endocrine system: GH and IGF-1 regulation
- Musculoskeletal system: muscle growth, strength, and recovery
- Metabolic system: fat metabolism and energy balance
- Aging research: tissue repair, cellular resilience, and longevity studies
Targeted Tissues & Cells
- Skeletal muscle cells: GH-mediated protein synthesis and hypertrophy
- Adipocytes: fat utilization and lipolysis
- Pituitary gland: direct stimulation of GH release
- Connective tissue & cartilage: support for repair and recovery
Research Conditions of Interest
- Age-related GH decline
- Sarcopenia and muscle wasting
- Metabolic disorders, obesity, and insulin resistance
- Exercise physiology and recovery studies
Primary Research Applications
- Studying GH regulation and endocrine modulation
- Evaluating muscle growth, strength, and recovery mechanisms
- Investigating metabolic effects and fat utilization
- Exploring anti-aging and tissue repair potential
Biological Mechanisms
- Mimics natural GHRH, binding to GHRH receptors in the pituitary
- CJC-1295 with DAC: extended half-life (~1 week), sustained GH elevation
- CJC-1295 no DAC: short half-life (~30 minutes), requires frequent dosing
- Increases IGF-1 production downstream
- Supports anabolic processes, fat metabolism, and cellular repair
Metabolic / Endocrine Relevance
- Enhances muscle protein synthesis and recovery
- Promotes lipolysis and energy expenditure
- Improves endocrine balance due to selective GH stimulation
Potential Side Effects
- Mild injection-site irritation
- Temporary water retention or edema
- Headache or dizziness in some models
Signs of Overuse
- GH-related side effects: joint pain, swelling, carpal tunnel symptoms
- Persistent fatigue or unusual hormonal imbalance
Long-Term Considerations
- Limited long-term human studies, particularly for chronic DAC use
- Theoretical risk of GH desensitization with continuous high dosing
Red Flags to Monitor
- Abnormal GH or IGF-1 levels
- Persistent systemic fatigue or metabolic disruption
- Unexpected edema or soft-tissue swelling
Safe Stack Combinations
- CJC-1295 + Ipamorelin β synergistic GH pulse stimulation
- CJC-1295 + resistance training β enhanced muscle growth and recovery
- CJC-1295 + metabolic studies β combined anabolic and fat metabolism benefits
Dosing Guidelines (Research Use Only)
- CJC-1295 with DAC: 1β2 mg per week
- CJC-1295 no DAC: 100β200 Β΅g, 2β3 times daily
- Duration: 4β12 weeks depending on study goals
Cautions in Combination
- Avoid stacking with unmonitored GH or insulin-like agents
- Monitor GH, IGF-1, and metabolic markers in combined protocols
Compatibility Notes
- Particularly suitable for aging, muscle wasting, and metabolic studies
- Supports anabolic and recovery outcomes, rather than direct fat-loss alone
- Applications in sarcopenia, muscle atrophy, and post-injury recovery
- Synergistic effects with Ipamorelin and other GH secretagogues
- Investigation in fat metabolism and energy expenditure models
- Long-term implications for aging, endocrine health, and tissue repair
- Exploration of quality-of-life and resilience outcomes in older populations
CJC-1295, both with DAC and no DAC, is a versatile GHRH analog that selectively stimulates GH release with downstream anabolic and metabolic effects. Its ability to support muscle growth, recovery, fat metabolism, and potential anti-aging applications makes it a valuable tool for research. Careful experimental design and monitoring are essential to ensure safety and fully understand its therapeutic potential.